Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473888 · ClinicalTrials.gov registry record · Phase 1
A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes
A Phase 1 study, sponsored by Tasly Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01473888: Completed Phase 1 study, sponsored by Tasly Pharmaceuticals.
NCT01473888 is a Phase 1 study that has completed, run by Tasly Pharmaceuticals. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473888, a Phase 1 study, has completed, sponsored by Tasly Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enzymes. This study will help determine which types of drugs may interact with T89.
Primary Outcome
caffine: AUC(0-12h)\&Cmax; Omeprazole:AUC(0-12h)\& Cmax; Midazolam:AUC(0-12h)\& Cmax; Dextromethorphan:Dextromethorphan/Dextrorphan(12h Urine) S-warfarin: AUC(0-96h)\& Cmax;
Interventions
- DRUG T89(Dantonic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
What the finished NCT01473888 record still lists
NCT01473888 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 1 intervention - of which T89(Dantonic) is the first listed.
NCT01473888 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01473888 about?
NCT01473888 is a clinical study titled "A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes". Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enzymes. This study will help determine which types of drugs may interact with T89.
What is the current status of trial NCT01473888?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2011-01. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01473888?
The interventions under investigation include: T89(Dantonic) (DRUG).
Who is sponsoring clinical trial NCT01473888?
This trial is sponsored by Tasly Pharmaceuticals, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01473888's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia